Sanofi
74.24EUR
-0.4600 (-0.62%)
Revenue
| (EUR) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 40.6B | 41.6B | 44.3B | 46.7B | 47.7B | 50.8B |
| Q1 | — | — | — | — | 11.2B | — |
| Q2 | — | — | — | 10.7B | 12.3B | — |
| Q3 | — | — | — | 13.2B | 13.2B | — |
| Q4 | — | — | — | 12.2B | 12.5B | — |
Revenue
| (EUR) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 5.37 | 4.31 | 4.59 | 6.40 | 8.58 | 9.09 |
| Q1 | — | — | — | 1.52 | 1.34 | — |
| Q2 | — | — | — | 3.24 | .290 | — |
| Q3 | — | — | — | — | 2.89 | — |
| Q4 | — | — |
Fiscal period: Reported, Estimated. Reported figures: Yahoo Finance (limited history). Estimates are sell-side consensus for periods that have not reported. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| — |
| -.660 |
| 1.77 |
| — |